Table 2. Associations between CD117 expression in fibroblast-like stromal cells and clinicopathological features (N = 242).
| CD117 expression, n (%) | ||||
| Total N | negative | positive | p value | |
| Age group | 0.411 | |||
| ≤59 | 121 | 104 (86.0) | 17 (14.0) | |
| ≥60 | 111 | 91 (82.0) | 20 (18.0) | |
| missing | 10 | |||
| FIGO stage | 0.019 | |||
| I+II | 46 | 44 (95.7) | 2 (4.3) | |
| III+IV | 196 | 160 (81.6) | 36 (18.4) | |
| Differentiation grade | 0.010 | |||
| well | 19 | 19 (100) | 0 (0) | |
| moderately | 62 | 55 (88.7) | 7 (11.3) | |
| poorly | 133 | 105 (78.9) | 28 (21.1) | |
| missing | 28 | |||
| Histological subtype | 0.012 | |||
| serous | 163 | 131 (80.4) | 32 (19.6) | |
| MUC+END+CLE | 48 | 47 (97.9) | 1 (2.1) | |
| UND+MIX+others | 27 | 23 (85.2) | 4 (14.8) | |
| missing | 4 | |||
MUC, Mucinous carcinoma; END, Endometrioid carcinoma; CLE, Clear cell carcinoma; UND, Undifferentiated carcinoma; MIX, Mixed carcinoma.